Rocket Pharmaceuticals

Seeking gene therapy cures

Founded 2015

Cranbury, United States 222 employees IPO Total: $725.80M Biotechnology, Health Care +1

General Information

Company Name Rocket Pharmaceuticals

Founded Year 2015

Location

Cranbury, United States

Founders / Decision Makers

Employees 222

Industries Biotechnology, Health Care, Pharmaceutical

Funding Stage IPO

Business Model B2B, B2C, B2D

Revenue Model Product Sales, Licensing, Service Fee

Social

BounceWatch is an independent company data service, not affiliated with Rocket Pharmaceuticals. To contact Rocket Pharmaceuticals, visit rocketpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rocket Pharmaceuticals compare?

A PDF of Rocket Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rocket Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 12, 2026

Rocket Pharmaceuticals' CEO Gaurav Shah, MD, participated in the Meeting on the Mesa, where he joined industry leaders to share lessons on clinical safety, manufacturing, and patient access.

Get alerts when Rocket Pharmaceuticals shows new signals

About Rocket Pharmaceuticals

Rocket Pharmaceuticals is a fully-integrated, clinical-stage company with a mission of seeking gene therapy cures. Founded in 2015 and headquartered in the United States, the company positions itself at the intersection of Biotechnology, Health Care, and Pharmaceutical industries.

Known for its dedication to both pipeline advancement and team well-being, Rocket Pharma emphasizes the importance of collaborative, hands-on contributions from its team members. The company is driven by scientific innovation and has gained increasing recognition as a leading player in biotechnology. Beyond its mission-driven culture, Rocket Pharmaceuticals offers a competitive compensation package that includes a substantial 401K match and stock options, along with excellent health benefits.

On 12 September 2023, Rocket Pharmaceuticals continued its growth trajectory with a Post-IPO Equity investment, highlighting continued investor confidence in its strategic direction and scientific capabilities.

Business keywords: Gene Therapy, Rare Diseases, Clinical Stage Company, Lentiviral-based Therapies, AAV-based Therapies, Fanconi Anemia, Bone Marrow Disorders, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1, Infantile Malignant Osteopetrosis, Pediatric Disease Treatments, Cancer-related Genetic Disorders

Services & Products

Development of gene therapies

Conducting clinical trials

Providing educational resources

Patient advocacy and support

Target Customers

Patients with rare genetic diseases Healthcare professionals Academic researchers Pharmaceutical partners

Funding Rounds & Investors (13)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Post IPO Convertible	Undisclosed	1	Cantor Fitzgerald	01 Mar 2026
Post-IPO Equity	$165.00M	-		01 Dec 2024
Post-IPO Equity	$150.00M	-		01 Sep 2023
Post-IPO Equity	$100.30M	-		01 Oct 2022
Post-IPO Equity	$26.40M	1	RTW Investments	01 Aug 2021
Grant	$3.70M	1	California Institute for Regenerative Medicine	01 Nov 2020
Post-IPO Equity	$85.00M	-		01 Dec 2019
Post-IPO Equity	$90.60M	-		01 Apr 2019
Post-IPO Equity	$63.30M	-		01 Nov 2018
IPO	Undisclosed	-		01 Jan 2018

View All 13 Funding Rounds

Rocket Pharmaceuticals Alternatives & Competitors

View All Alternatives

Rocket Pharmaceuticals vs

bluebird bio United States

Pursuing curative gene therapies to give patients and their families more bluebird days.

IPO

548 employees

Biotechnology, Health Care

Compare Rocket Pharmaceuticals vs bluebird bio

Rocket Pharmaceuticals vs

AAVantgarde

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the disease

Series A

70 employees

Biotechnology, Health Care

Rocket Pharmaceuticals vs

Mustang Bio United States

A fortress biotech Company

IPO

43 employees

Biotechnology, Pharmaceutical

Also compare with:

Adverum Biotechnologies View all alternatives

FAQ About Rocket Pharmaceuticals

Seeking gene therapy cures

Rocket Pharmaceuticals was founded in 2015.

Rocket Pharmaceuticals is headquartered in Cranbury, United States.

Rocket Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Gene Therapy, Rare Diseases, Clinical Stage Company and Lentiviral-based Therapies. Its customers include Patients with rare genetic diseases, Healthcare professionals and Academic researchers.

Rocket Pharmaceuticals has a B2B, B2C and B2D business model. Its revenue comes from Product Sales, Licensing and Service Fee.

Rocket Pharmaceuticals has approximately 222 employees.

Rocket Pharmaceuticals has completed 13 funding rounds, raising a total of $725.80M. The latest funding stage is IPO.

Rocket Pharmaceuticals offers: Development of gene therapies, Conducting clinical trials, Providing educational resources, Patient advocacy and support.

Top alternatives and competitors to Rocket Pharmaceuticals include bluebird bio, AAVantgarde, Mustang Bio, Orchard Therapeutics - U.S., Adverum Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Rocket Pharmaceuticals and bluebird bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rocket Pharmaceuticals, https://bouncewatch.com/company/rocket-pharmaceuticals, updated 25 June 2026. When citing, please name BounceWatch and link this page.

Rocket Pharmaceuticals

General Information

Discover More

What changed at Rocket Pharmaceuticals recently?

About Rocket Pharmaceuticals

Services & Products

Target Customers

Funding Rounds & Investors (13)

Rocket Pharmaceuticals Alternatives & Competitors

FAQ About Rocket Pharmaceuticals